Empro Group Inc. (EMPG): Total Asset Value of Company

Empro Group Inc (EMPG) is expanding its presence in the Asian market, although marketing expenses are limiting net profit growth. The business relies on products with high macro-resilience, for which demand is moderately dependent on consumer income and increases during the spring. This chart of total asset prices on GURU.Markets, with a value of 0.00, complements data regarding management's strategy to implement innovations within the premium dermatology segment.

Empro Group Inc (EMPG) Company Total Assets: for the period 07/03/2025 - 10/25/2025

Comprehensive metric breakdowns and analytics for Empro (EMPG)

- price and consensus price forecast:

Price Rate Chart empro.my|EMPG - Price Target Chart

- market capitalization data:

Market Valuation Empro Corporation|EMPG - Enterprise Value

- book capitalization data:

Accounting Value of a Share Empro Group|EMPG - Book Capitalization|Market Capitalization to Book Value Ratio empro.my|EMPG - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio Empro Group Inc|EMPG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Empro Corporation|EMPG - Company Aggregate Debts|Debts to Book Capitalization Empro Corporation|EMPG - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Empro Group

Fundamental valuation:EMPG, empro.my

The synergy between medical innovations and the retail aesthetics segment allows Empro Group Inc (EMPG) to effectively expand its asset base and market influence. By analyzing asset and resource fluctuations, the investor assesses the total value of assets and liabilities, reverse-calculated via return on assets (ROA), which enables a precise determination of the business development vector and confirms the stability of the issuer's capital.

Competitors of Empro Group Inc (EMPG)

KRYS (krystalbio.com) - Company Balance Sheet Assets|Aggregate Company Assets Apogee Therapeutics, Inc. APGE|Total Asset Value of Company Arcutis|Vericel Corp. (VCEL) - Company Total Assets|Aggregate Asset Value Oruka Pharma (ORKA)|Company Total Assets SMTI (Sanara MedTech)|DBV Tech - Company Total Assets|Aggregate Company Assets Solesence Inc. (SLSN)|DERM: Aggregate Asset Value|FBRX (Forte Biosciences, Inc) - Aggregate Company Assets|Sol-Gel Technologies, Ltd. (SLGL) - Cumulative Company Assets|AXIL (AXIL Brands Inc) - Company Total Assets|Company Total Assets medicuspharma.com (MDCX)|Verrica Pharmaceuticals (VRCA) - Cumulative Company Assets|Aggregate Asset Value HOTH (hoththerapeutics.com)|Aggregate Company Assets BFRI|VYNE Therapeutics, Inc. - Company Total Asset Base|Sonoma Pharma - Aggregate Company Assets|QNRX - Company Total Assets|Azitra - Company Total Assets|DRMA (Dermata Therapeutics Inc) - Company Total Asset Base|Aggregate Company Assets Elevai Skincare (ELAB)|Total Business Assets Revance Therapeutics Inc